Basic Information
LncRNA/CircRNA Name | NEAT1 |
Synonyms | NEAT1, LINC00084, NCRNA00084, TncRNA, VINC |
Region | GRCh38_11:65422774-65445540 |
Ensemble | ENSG00000245532 |
Refseq | NR_028272 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | osteosarcoma |
ICD-0-3 | NA |
Methods | qPCR, Western blot, Luciferase reporter assay, RNAi, other |
Sample | OS cell lines (KHOS, 143B, SAOS-2, SOSP-9697,MG-63) |
Expression Pattern | up-regulated |
Function Description | Here, we found that NEAT1 can modulate OS development via sponging miR-339-5p. MiR-339-5p was significantly decreased in OS cells, and its overexpression can remarkably repress the OS proliferation. These results indicated that NEAT1 could function as a tumor oncogene in OS by inhibiting miR-339-5p in vitro. Then, the following assays validated that transforming growth factor ?1 (TGF-?1) can act as a functional target of miR-339-5p in OS cells. Finally, we indicated that NEAT1 could mediate TGF-?1 expression by competitively sponging miR-339-5p. NEAT1 induced OS cell proliferation and cell mobility by binding to miR-339-5p and increasing TGF-?1 in OS. It was demonstrated in our study that lncRNA NEAT1 could impede miR-339-5p expression to maintain the expression of TGF-?1, which led to the development of OS. |
Pubmed ID | 30203547 |
Year | 2019 |
Title | NEAT1 Induces Osteosarcoma Development by Modulating the miR-339-5p/TGF-?1 Pathway |
External Links
Links for NEAT1 | GenBank HGNC NONCODE |
Links for osteosarcoma | OMIM COSMIC |